Certain foods and nutrients were found to influence the risk of developing liver cancer. For example, aflatoxins (toxins from ...

The UK’s National Institute for Health and Care Excellence (NICE) has issued a positive recommendation for the use of ...

Japanese drugmaker Eisai revealed that its in-house discovered tyrosine kinase inhibitor, Lenvima (lenvatinib mesylate), in combination with the anti-PD-1 antibody, pembrolizumab, and transarterial ...

Espervita Therapeutics, a biotechnology company developing targeted metabolic reprogramming therapies, announced the publication in Nature featuring groundbreaking preclinical data for the treatment ...

US researchers analyzed national death certificate data to compare trends in hepatocellular carcinoma (HCC)-related mortality and underlying etiologies of chronic liver disease linked to HCC-related ...

STUTTGART, Germany I July 30, 2025 I La Merie Publishing released its newest product entitled: Glypican-3 (GPC3) Targeted Therapy: a Competitor Analysis.

A new study has established that the follow-up of the fatty liver index (FLI), both baseline and longitudinally, is an ...

AstraZeneca has received a positive recommendation from NICE for the use of Imfinzi (durvalumab) with Imjudo (tremelimumab) ...

Weight loss without diet changes, along with loss of appetite, can be initial warning signs of liver cancer. Your stomach ...

A new Lancet study warns liver cancer cases could nearly double by 2050, if no action is taken. The authors emphasise ...

The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD ...

“There are a lot of treatment options depending on how bad your liver disease is, how many cancers in the liver you have, how ...